<page><tag>3</tag><title>Vioxx Will Weigh as Drugmakers Consider Strategy</title><text>The withdrawal of Merck  amp; Co. Inc. #39;s arthritis drug Vioxx will make it harder for drug companies to win approval for products aimed at big patient populations as regulators </text></page>